Tweaking Microtubules to Treat Scleroderma
Step 1: TGFβ binding to a type II receptor causes the receptor to recruit and phosphorylate a type I receptor. Step 2: phosphorylated type I receptor recruits and phosphorylates Smad2 or Smad3, upon which the Smads open up and expose a dimerization surface. Step 3: phosphorylated Smad2 or Smad3 dissociates from the receptor and oligomerizes with inhibitory Smad4. Step 4: the Smad2/3–Smad4 complex migrates to the nucleus, recruits other gene regulatory proteins (blue), and activates transcription of specific target genes.
Publication
Tweaking Microtubules to Treat Scleroderma. (2005) Jacob M van Laar, et al. PLoS Med. 2005 Dec;2(12):e415. Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | Smad2,3 | SMAD2 | ncbigene_symbol | SMAD2 | 4087 |
| Homo sapiens | Primates | Smad2,3 | SMAD3 | ncbigene_symbol | SMAD3 | 4088 |
| Homo sapiens | Primates | Step | STEP | ncbigene_synonym | PTPN5 | 84867 |
| Homo sapiens | Primates | Smad4 | SMAD4 | ncbigene_symbol | SMAD4 | 4089 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|